Privilege escalation in Mcafee Total Protection (Mtp)

CVE-2021-23877

Privilege escalation vulnerability in the Windows trial installer of McAfee Total Protection (MTP) prior to 16.0.34_x may allow a local user to run arbitrary code as the admin user by replacing a specific temporary file created during the installation of the trial version of MTP.

Vulnerability class: Privilege Escalation

Published · last modified .

CVSS v3 metric

CVSS v3 base score 6.7 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.004 (28.5th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 29th percentile — 28.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2021-23877: held from 0.004 to 0.004.

EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2021-23877?
CVE-2021-23877 is a medium-severity vulnerability in Mcafee Total Protection (Mtp), classified under Improper Privilege Management. CVSS score: 6.7/10. Published 2021-10-26.
How severe is CVE-2021-23877?
Medium severity. CVSS v3 base score is 6.7 out of 10.